Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
In this analysis, DFP appeared to be the most cost-effective treatment available for managing chronic iron overload in β-thalassaemia patients. Use of DFP in these patients could therefore result in substantial cost savings. </AbstractSection> Copyright The Author(s) 2013
Year of publication: |
2013
|
---|---|
Authors: | Bentley, Anthony ; Gillard, Samantha ; Spino, Michael ; Connelly, John ; Tricta, Fernando |
Published in: |
PharmacoEconomics. - Springer, ISSN 1170-7690. - Vol. 31.2013, 9, p. 807-822
|
Publisher: |
Springer |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Bentley, Anthony, (2013)
-
Bentley, Anthony, (2013)
-
Dakin, Helen, (2011)
- More ...